Board of directors
McMaster Innovation Park’s Board of Directors is comprised of experts in their field that bring unsurpassed knowledge and expertise, not only from McMaster University but also from the private sector. Their personal and professional accomplishments set them apart as leaders in their field and we are pleased to have them on our team. Our innovative team brings together diversified experience that strategically aligns us toward success. Governance Policy: Mandate for an Individual Director.
- Dr. Robert Baker, Chair
- Dr. Stephen Collins
- Roger Couldrey
- Dr. Patrick Deane
- Sean Donnelly
- Dr. Hadi Mahabadi
- Dr. John Rudolph
- Stephanie McLarty
- Michael Hanna
- Evelyn Pau
As McMaster’s Vice-President, Research, Dr. Baker is responsible for supporting, promoting and advancing research at the University, as well as fostering the relationship between research and teaching. He oversees a research enterprise consistently ranked among Canada’s best; with a research intensity level nearly double the national average. Before taking on this role, Dr. Baker spent the three years as Dean of McMaster’s Faculty of Science, where he championed high quality and innovative undergraduate and graduate programs, and increased opportunities to achieve research excellence for all faculty and students.
Prior to joining McMaster, Dr. Baker held several progressive senior administrative positions at the University of Toronto: Inaugural Chair of Biology and Associate Dean of Sciences at University of Toronto Mississauga; Chair of Zoology in the Faculty of Arts & Sciences; Chair of Ecology and Evolutionary Biology; Vice-Dean, Graduate Education and Research, Faculty of Arts & Sciences; and Vice-Dean, Research and Infrastructure.
Dr. Baker received his PhD in 1981 from the University of Alberta. His research explores the evolution and ecological significance of anti-predator and anti-parasite behaviour of aquatic insects and amphibians.
Dr. Collins obtained his medical training at London University in England where he later specialized in internal medicine. He trained in gastroenterology at McMaster University in Canada before completing three years of research training in cell biology at the Digestive Diseases Branch, National Institutes of Health (NIH) in Bethesda, Maryland, USA. He has been on staff at McMaster University since 1981 where he was the Director of the Intestinal Diseases Research Unit from 1983-1993, and Head of the Division of Gastroenterology from 1993-2006. In May, 2006, Dr. Collins became Associate Dean, Research, in the Faculty of Health Sciences at McMaster University and holds the title of Distinguished University Professor - the highest rank awarded by the University. Dr. Collins is also a member of the Medical Review Panel for the Gairdner Foundation International Awards. Recipients of this prestigious award often go on to win a Nobel Prize in Medicine.
Roger was appointed Vice-President (Administration) of McMaster University in April 2010, having spent more than a decade on the Board of Governors, much of it as chair of the Finance and Audit Committees. He came to McMaster after a 38 year career in Financial Services including 30 years at Bank of Montreal where he held executive roles in Human Resources, Electronic Financial Services and Personal and Commercial Banking. He was a founding executive and subsequent President of epost, the electronic post office, now a wholly owned subsidiary of Canada Post Corporation.
More recently he was a founding executive of CommunityLend, a web-based peer to peer lending organization. In between he was a member of the Senior Management team of Orlick Industries, an owner managed auto parts manufacturer in Hamilton. He has succeeded in many different roles and in many different types of organizations. He has a long history of community involvement having been Chair of the United Way, President of the Art Gallery of Hamilton and Vice-Chair of the Royal Botanical Gardens among others.
Patrick Deane is the seventh President and Vice-Chancellor of McMaster University, a position he has held since 2010. As President, Dr. Deane is focused on promoting and supporting research, strengthening the connections between the University and the local and global communities that we serve and ensuring a distinctive, personalized and engaging experience for McMaster’s students.
Dr. Deane is also a Professor in the Department of English and Cultural Studies, with his principal research interest being British writing of the period 1914-1945. He has written two books, as well many articles and other publications, and was honoured with the first John Charles Polanyi Prize for Literature in 1988.
Sean was appointed to the position of President and CEO ArcelorMittal Dofasco and Member of the ArcelorMittal Management Committee in 2014. He has held various leadership positions including Vice President, Manufacturing, Vice President Technology, Director Quality Systems & Manufacturing Technology, General Manager, Market Development and Product Applications, New Product Development Process Owner, Galvanize Technology Business Unit Manager and Operations Foreman.
Sean joined Dofasco in 1981 as a Production Engineer in Galvanize after graduating from Hamilton's McMaster University with a degree in Metallurgical Engineering. He is a member of several Boards, including McMaster University Board of Governors and McMaster Innovation Park and Chair of the Canadian Steel Producers Association.
Dr. Mahabadi is an innovation leader and R&D executive with over 40 years of hands on experience in invention and commercialization of novel technology and managing innovation, including 5 years as CanWin Consulting Inc. President and 7 years as Vice President of Xerox innovation Group and Director of Xerox Research Centre of Canada (XRCC). Dr. Mahabadi has been instrumental in creating an environment that increased innovativeness and successful commercialization of many break-through technologies in Xerox and many start-ups in Canada.
His Scientific achievements, managerial capabilities and innovation leadership efforts were recognized by many awards, including his 2012 appointment as Officer of the Order of Canada as an innovation leader and for his commitment to promoting scientific development in Canada. He has also received the Queen’s Diamond Jubilee Medal.
Dr. Mahabadi has also been involved in helping to shape science, technology and innovation strategy/ direction in Canada and advancing science, technology and innovation agenda nationally and internationally. He has served on a few national and regional committees/taskforces and boards such as the NSERC Private Sector Advisory and the Council of Canadian Academies.
Dr. John R. Rudolph is the Chief Information and Data Security legal counsel for Eli Lilly and Company, one of the world’s leading pharmaceutical companies. In this role, he advises the company on all legal matters arising in connection with information and cyber security. Prior to this, John has held a number of roles within Lilly including General counsel to Lilly Diabetes’ global organization and General Counsel for Eli Lilly Canada. Before joining Lilly Canada in 2008 he was an Assistant General Counsel at Pfizer Inc. in Groton/New London Connecticut, USA, where he was responsible for a variety of legal matters and was a member of the senior management team for one of the company’s largest Research and Development sites in the world. John moved to Connecticut from Pfizer Canada where he was Vice President, Legal and General Counsel, as well as Chief Privacy officer to Pfizer’s Canadian affiliate. Prior to his work in the pharmaceutical industry John was a partner at Bereskin and Parr where he practiced patent law in the field of Biotechnology.
John has a Bachelor of Science degree in Physiology and Zoology and a Master of Science degree in Physiology, both from the University of Toronto. Subsequently he received a Ph.D. in Medical Sciences from McMaster University. John then obtained his law degree from the University of Ottawa graduating cum Laude. John is called to the Bar of Ontario, as well as the Bar of each of Massachusetts and Indiana. He is also a registered Canadian and U.S. patent agent. John has authored or co-authored many scientific and legal publications, and has lectured on a range of legal and scientific topics, as well as appearing on CHCH television speaking about intellectual property matters. He is a member of a number of professional organizations, and in 2005 he was admitted to the Honour Society of the University of Ottawa law school primarily for his roles in business and as an advocate for strong intellectual property rights in Canada.
Stephanie McLarty is an award-winning entrepreneur and champion of corporate sustainable practices. She is Founder & CEO of REfficient, where companies and individuals buy refurbished and reclaimed products in the Telecom, AV and building materials spaces. Since launching REfficient in 2010, Stephanie has led the growth of the company to a customer base spanning 14 countries on 4 continents. REfficient was Hamilton’s first Certified B Corp, meaning the company is for profit and for good, and was named four times to the “Best for the World” list for the company’s environmental impact. Stephanie is also Partner in the CoBuild Industrial Coworking Space and an avid real estate investor.
Stephanie is a Member of the Canadian National Committee for the International Electrotechnical Commission (IEC) and has represented Canada internationally for reuse and recycling standards since 2008. In 2014, she was recognized with the inaugural Young Leader Award through Standards Council of Canada for her contributions representing Canada. She also sits on the board executives of the McMaster Alumni Association and Wildlife Preservation Canada.
Stephanie has a degree in Arts & Science from McMaster University and a MA from the University of Innsbruck, Austria.
Evelyn Pau is an Associate at Bloom Burton & Co., and joined as an Analyst in October 2012. At Bloom Burton, Evelyn’s responsibilities include monetization planning, strategy consulting, and scientific, clinical and medical due diligence for pharmaceutical, biotechnology, and healthcare companies. Her area of focus is in academic commercialization and preclinical stage biotechnology companies.
Prior to joining Bloom Burton, Evelyn gained business development, due diligence, and strategy consulting experience in biotechnology and healthcare. As a business development analyst at Tornado Medical Systems (now Tornado Spectral Systems), Evelyn performed commercial and intellectual property due diligence in the medical devices market for the early-stage medical imaging and spectroscopy company. At SECOR Consulting (now KPMG), Evelyn was a research fellow for a strategic planning project for a healthcare government agency.
Evelyn completed her PhD in Immunology at the University of Toronto, specializing in genetics and autoimmunity, and her Bachelor of Medical Sciences Honours in Microbiology and Immunology at Western University.